nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—PLA2G1B—mouth—pharynx cancer	0.0163	0.0639	CbGeAlD
Dexamethasone—CYP2E1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0162	0.0218	CbGpPWpGaD
Dexamethasone—CYP3A43—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0157	0.0211	CbGpPWpGaD
Dexamethasone—CYP1A1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0153	0.0206	CbGpPWpGaD
Dexamethasone—CYP2E1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0142	0.0191	CbGpPWpGaD
Dexamethasone—CYP3A43—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0137	0.0185	CbGpPWpGaD
Dexamethasone—CYP1A1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0134	0.018	CbGpPWpGaD
Dexamethasone—ANXA1—mouth—pharynx cancer	0.0125	0.0489	CbGeAlD
Dexamethasone—CYP17A1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.012	0.0161	CbGpPWpGaD
Dexamethasone—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0115	0.0155	CbGpPWpGaD
Dexamethasone—CYP11A1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.011	0.0147	CbGpPWpGaD
Dexamethasone—CYP4A11—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0109	0.0146	CbGpPWpGaD
Dexamethasone—ANXA1—neck—pharynx cancer	0.0107	0.0418	CbGeAlD
Dexamethasone—CYP17A1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0105	0.0141	CbGpPWpGaD
Dexamethasone—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0101	0.0136	CbGpPWpGaD
Dexamethasone—CYP11A1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00963	0.0129	CbGpPWpGaD
Dexamethasone—CYP4A11—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00953	0.0128	CbGpPWpGaD
Dexamethasone—PLA2G1B—epithelium—pharynx cancer	0.00949	0.0372	CbGeAlD
Dexamethasone—CYP3A43—Biological oxidations—CNDP2—pharynx cancer	0.00921	0.0124	CbGpPWpGaD
Dexamethasone—ANXA1—parotid gland—pharynx cancer	0.00868	0.034	CbGeAlD
Dexamethasone—CYP3A43—Biological oxidations—ADH7—pharynx cancer	0.00833	0.0112	CbGpPWpGaD
Dexamethasone—ANXA1—saliva-secreting gland—pharynx cancer	0.00832	0.0326	CbGeAlD
Dexamethasone—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00754	0.0101	CbGpPWpGaD
Dexamethasone—CYP3A43—Biological oxidations—ADH1B—pharynx cancer	0.0073	0.00981	CbGpPWpGaD
Dexamethasone—CYP19A1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00727	0.00976	CbGpPWpGaD
Dexamethasone—ANXA1—epithelium—pharynx cancer	0.00726	0.0284	CbGeAlD
Dexamethasone—CYP17A1—Biological oxidations—CNDP2—pharynx cancer	0.00705	0.00947	CbGpPWpGaD
Dexamethasone—CYP1B1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.007	0.0094	CbGpPWpGaD
Dexamethasone—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00661	0.00887	CbGpPWpGaD
Dexamethasone—CYP4A11—NRF2 pathway—ADH7—pharynx cancer	0.00658	0.00884	CbGpPWpGaD
Dexamethasone—CYP11A1—Biological oxidations—CNDP2—pharynx cancer	0.00645	0.00866	CbGpPWpGaD
Dexamethasone—ANXA1—trachea—pharynx cancer	0.00642	0.0251	CbGeAlD
Dexamethasone—CYP4A11—Biological oxidations—CNDP2—pharynx cancer	0.00638	0.00857	CbGpPWpGaD
Dexamethasone—CYP19A1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00638	0.00856	CbGpPWpGaD
Dexamethasone—CYP17A1—Biological oxidations—ADH7—pharynx cancer	0.00638	0.00856	CbGpPWpGaD
Dexamethasone—CYP3A7—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00632	0.00848	CbGpPWpGaD
Dexamethasone—CYP1B1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00614	0.00824	CbGpPWpGaD
Dexamethasone—NR3C2—Preimplantation Embryo—CDH1—pharynx cancer	0.00591	0.00793	CbGpPWpGaD
Dexamethasone—PLA2G1B—head—pharynx cancer	0.00589	0.0231	CbGeAlD
Dexamethasone—CYP11A1—Biological oxidations—ADH7—pharynx cancer	0.00583	0.00783	CbGpPWpGaD
Dexamethasone—CYP2A6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00579	0.00777	CbGpPWpGaD
Dexamethasone—CYP4A11—Biological oxidations—ADH7—pharynx cancer	0.00577	0.00775	CbGpPWpGaD
Dexamethasone—NR3C2—parotid gland—pharynx cancer	0.00562	0.022	CbGeAlD
Dexamethasone—CYP17A1—Biological oxidations—ADH1B—pharynx cancer	0.00559	0.00751	CbGpPWpGaD
Dexamethasone—ANXA1—lymphoid tissue—pharynx cancer	0.00559	0.0219	CbGeAlD
Dexamethasone—CYP3A7—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00554	0.00743	CbGpPWpGaD
Dexamethasone—NR3C2—saliva-secreting gland—pharynx cancer	0.00539	0.0211	CbGeAlD
Dexamethasone—NR0B1—Validated nuclear estrogen receptor alpha network—CCND1—pharynx cancer	0.00533	0.00716	CbGpPWpGaD
Dexamethasone—NR3C2—brainstem—pharynx cancer	0.00528	0.0207	CbGeAlD
Dexamethasone—CYP11A1—Biological oxidations—ADH1B—pharynx cancer	0.00511	0.00687	CbGpPWpGaD
Dexamethasone—CYP2A6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00508	0.00681	CbGpPWpGaD
Dexamethasone—ANXA1—spinal cord—pharynx cancer	0.00507	0.0199	CbGeAlD
Dexamethasone—CYP4A11—Biological oxidations—ADH1B—pharynx cancer	0.00506	0.0068	CbGpPWpGaD
Dexamethasone—CYP4A11—PPAR Alpha Pathway—CCND1—pharynx cancer	0.00499	0.0067	CbGpPWpGaD
Dexamethasone—CYP2B6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00467	0.00627	CbGpPWpGaD
Dexamethasone—CYP2E1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00457	0.00614	CbGpPWpGaD
Dexamethasone—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00457	0.00613	CbGpPWpGaD
Dexamethasone—ANXA1—head—pharynx cancer	0.0045	0.0176	CbGeAlD
Dexamethasone—CYP1A1—mouth—pharynx cancer	0.00447	0.0175	CbGeAlD
Dexamethasone—ABCC2—NRF2 pathway—ADH7—pharynx cancer	0.00444	0.00596	CbGpPWpGaD
Dexamethasone—PGR—epithelium—pharynx cancer	0.00437	0.0171	CbGeAlD
Dexamethasone—CYP1A1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00431	0.00579	CbGpPWpGaD
Dexamethasone—CYP19A1—Biological oxidations—CNDP2—pharynx cancer	0.00427	0.00574	CbGpPWpGaD
Dexamethasone—NR3C2—trachea—pharynx cancer	0.00415	0.0163	CbGeAlD
Dexamethasone—CYP1B1—Biological oxidations—CNDP2—pharynx cancer	0.00411	0.00552	CbGpPWpGaD
Dexamethasone—CYP2B6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0041	0.0055	CbGpPWpGaD
Dexamethasone—CYP17A1—head—pharynx cancer	0.00404	0.0158	CbGeAlD
Dexamethasone—CYP2E1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00401	0.00539	CbGpPWpGaD
Dexamethasone—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.004	0.00537	CbGpPWpGaD
Dexamethasone—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00395	0.00531	CbGpPWpGaD
Dexamethasone—CYP19A1—Biological oxidations—ADH7—pharynx cancer	0.00386	0.00519	CbGpPWpGaD
Dexamethasone—CYP1A1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00378	0.00508	CbGpPWpGaD
Dexamethasone—CYP11A1—head—pharynx cancer	0.00375	0.0147	CbGeAlD
Dexamethasone—PTGS2—mouth—pharynx cancer	0.00375	0.0147	CbGeAlD
Dexamethasone—CYP1B1—Biological oxidations—ADH7—pharynx cancer	0.00372	0.00499	CbGpPWpGaD
Dexamethasone—CYP3A7—Biological oxidations—CNDP2—pharynx cancer	0.00371	0.00498	CbGpPWpGaD
Dexamethasone—NR3C1—neck—pharynx cancer	0.0037	0.0145	CbGeAlD
Dexamethasone—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—pharynx cancer	0.00365	0.0049	CbGpPWpGaD
Dexamethasone—NOS2—ATF-2 transcription factor network—CCND1—pharynx cancer	0.00365	0.0049	CbGpPWpGaD
Dexamethasone—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00353	0.00474	CbGpPWpGaD
Dexamethasone—CYP2A6—NRF2 pathway—ADH7—pharynx cancer	0.00351	0.00471	CbGpPWpGaD
Dexamethasone—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00347	0.00465	CbGpPWpGaD
Dexamethasone—CYP2A6—Biological oxidations—CNDP2—pharynx cancer	0.0034	0.00456	CbGpPWpGaD
Dexamethasone—CYP19A1—Biological oxidations—ADH1B—pharynx cancer	0.00339	0.00455	CbGpPWpGaD
Dexamethasone—PGR—lymphoid tissue—pharynx cancer	0.00336	0.0132	CbGeAlD
Dexamethasone—CYP3A7—Biological oxidations—ADH7—pharynx cancer	0.00335	0.0045	CbGpPWpGaD
Dexamethasone—NR3C2—spinal cord—pharynx cancer	0.00328	0.0129	CbGeAlD
Dexamethasone—ABCG2—parotid gland—pharynx cancer	0.00327	0.0128	CbGeAlD
Dexamethasone—CYP1B1—Biological oxidations—ADH1B—pharynx cancer	0.00326	0.00438	CbGpPWpGaD
Dexamethasone—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00325	0.00436	CbGpPWpGaD
Dexamethasone—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00322	0.00432	CbGpPWpGaD
Dexamethasone—ANXA1—lymph node—pharynx cancer	0.00315	0.0124	CbGeAlD
Dexamethasone—ABCG2—saliva-secreting gland—pharynx cancer	0.00314	0.0123	CbGeAlD
Dexamethasone—CYP1A1—parotid gland—pharynx cancer	0.00311	0.0122	CbGeAlD
Dexamethasone—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00309	0.00415	CbGpPWpGaD
Dexamethasone—CYP2A6—Biological oxidations—ADH7—pharynx cancer	0.00307	0.00413	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.00306	0.00411	CbGpPWpGaD
Dexamethasone—NR3C1—parotid gland—pharynx cancer	0.00302	0.0118	CbGeAlD
Dexamethasone—CYP3A7—Biological oxidations—ADH1B—pharynx cancer	0.00294	0.00395	CbGpPWpGaD
Dexamethasone—NR3C2—head—pharynx cancer	0.00292	0.0114	CbGeAlD
Dexamethasone—NR3C1—saliva-secreting gland—pharynx cancer	0.00289	0.0113	CbGeAlD
Dexamethasone—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00285	0.00382	CbGpPWpGaD
Dexamethasone—NR3C1—brainstem—pharynx cancer	0.00283	0.0111	CbGeAlD
Dexamethasone—CYP1B1—lymphoid tissue—pharynx cancer	0.00283	0.0111	CbGeAlD
Dexamethasone—CYP17A1—lymph node—pharynx cancer	0.00283	0.0111	CbGeAlD
Dexamethasone—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00282	0.00379	CbGpPWpGaD
Dexamethasone—SLCO1A2—spinal cord—pharynx cancer	0.00281	0.011	CbGeAlD
Dexamethasone—ANXA1—Spinal Cord Injury—CCND1—pharynx cancer	0.00278	0.00373	CbGpPWpGaD
Dexamethasone—CYP2B6—Biological oxidations—CNDP2—pharynx cancer	0.00274	0.00368	CbGpPWpGaD
Dexamethasone—PGR—head—pharynx cancer	0.00271	0.0106	CbGeAlD
Dexamethasone—CYP2A6—Biological oxidations—ADH1B—pharynx cancer	0.0027	0.00362	CbGpPWpGaD
Dexamethasone—CYP2E1—Biological oxidations—CNDP2—pharynx cancer	0.00269	0.00361	CbGpPWpGaD
Dexamethasone—CYP3A5—Biological oxidations—CNDP2—pharynx cancer	0.00268	0.0036	CbGpPWpGaD
Dexamethasone—CYP11A1—lymph node—pharynx cancer	0.00263	0.0103	CbGeAlD
Dexamethasone—NOS2—AGE/RAGE pathway—EGFR—pharynx cancer	0.00262	0.00351	CbGpPWpGaD
Dexamethasone—CYP1A1—epithelium—pharynx cancer	0.0026	0.0102	CbGeAlD
Dexamethasone—NOS2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—pharynx cancer	0.00259	0.00347	CbGpPWpGaD
Dexamethasone—CYP1A1—Biological oxidations—CNDP2—pharynx cancer	0.00253	0.0034	CbGpPWpGaD
Dexamethasone—NR3C1—epithelium—pharynx cancer	0.00252	0.00988	CbGeAlD
Dexamethasone—SLCO1A2—head—pharynx cancer	0.0025	0.0098	CbGeAlD
Dexamethasone—CYP2B6—Biological oxidations—ADH7—pharynx cancer	0.00248	0.00333	CbGpPWpGaD
Dexamethasone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—pharynx cancer	0.00248	0.00333	CbGpPWpGaD
Dexamethasone—CYP19A1—head—pharynx cancer	0.00244	0.00956	CbGeAlD
Dexamethasone—CYP2E1—Biological oxidations—ADH7—pharynx cancer	0.00243	0.00326	CbGpPWpGaD
Dexamethasone—CYP3A5—Biological oxidations—ADH7—pharynx cancer	0.00242	0.00326	CbGpPWpGaD
Dexamethasone—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.00232	0.00312	CbGpPWpGaD
Dexamethasone—CYP1A1—trachea—pharynx cancer	0.0023	0.009	CbGeAlD
Dexamethasone—CYP1A1—Biological oxidations—ADH7—pharynx cancer	0.00229	0.00308	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.00228	0.00306	CbGpPWpGaD
Dexamethasone—CYP1B1—head—pharynx cancer	0.00228	0.00894	CbGeAlD
Dexamethasone—NR3C1—trachea—pharynx cancer	0.00223	0.00873	CbGeAlD
Dexamethasone—PTGS2—epithelium—pharynx cancer	0.00218	0.00855	CbGeAlD
Dexamethasone—ANXA1—Spinal Cord Injury—EGFR—pharynx cancer	0.00218	0.00293	CbGpPWpGaD
Dexamethasone—CYP2B6—Biological oxidations—ADH1B—pharynx cancer	0.00218	0.00292	CbGpPWpGaD
Dexamethasone—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—pharynx cancer	0.00217	0.00291	CbGpPWpGaD
Dexamethasone—CYP2E1—Biological oxidations—ADH1B—pharynx cancer	0.00213	0.00286	CbGpPWpGaD
Dexamethasone—CYP3A5—Biological oxidations—ADH1B—pharynx cancer	0.00213	0.00285	CbGpPWpGaD
Dexamethasone—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00212	0.00285	CbGpPWpGaD
Dexamethasone—CYP2D6—brainstem—pharynx cancer	0.00211	0.00826	CbGeAlD
Dexamethasone—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.0021	0.00282	CbGpPWpGaD
Dexamethasone—NOS2—Spinal Cord Injury—CCND1—pharynx cancer	0.0021	0.00281	CbGpPWpGaD
Dexamethasone—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.00207	0.00278	CbGpPWpGaD
Dexamethasone—NR3C2—lymph node—pharynx cancer	0.00204	0.008	CbGeAlD
Dexamethasone—CYP1A1—Biological oxidations—ADH1B—pharynx cancer	0.00201	0.0027	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—CNDP2—pharynx cancer	0.002	0.00269	CbGpPWpGaD
Dexamethasone—CYP2B6—lymphoid tissue—pharynx cancer	0.00194	0.00762	CbGeAlD
Dexamethasone—NR3C1—lymphoid tissue—pharynx cancer	0.00194	0.00761	CbGeAlD
Dexamethasone—PTGS2—trachea—pharynx cancer	0.00193	0.00756	CbGeAlD
Dexamethasone—ABCG2—spinal cord—pharynx cancer	0.00191	0.00749	CbGeAlD
Dexamethasone—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00191	0.00256	CbGpPWpGaD
Dexamethasone—PGR—lymph node—pharynx cancer	0.0019	0.00744	CbGeAlD
Dexamethasone—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.00189	0.00254	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00189	0.00254	CbGpPWpGaD
Dexamethasone—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.00187	0.00252	CbGpPWpGaD
Dexamethasone—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00186	0.0025	CbGpPWpGaD
Dexamethasone—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.00184	0.00247	CbGpPWpGaD
Dexamethasone—ANXA1—Spinal Cord Injury—TP53—pharynx cancer	0.00183	0.00246	CbGpPWpGaD
Dexamethasone—CYP2E1—lymphoid tissue—pharynx cancer	0.00182	0.00715	CbGeAlD
Dexamethasone—PLA2G1B—Metabolism—ADH7—pharynx cancer	0.00181	0.00243	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.00179	0.0024	CbGpPWpGaD
Dexamethasone—NR3C1—spinal cord—pharynx cancer	0.00176	0.0069	CbGeAlD
Dexamethasone—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.00172	0.00232	CbGpPWpGaD
Dexamethasone—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.00171	0.0023	CbGpPWpGaD
Dexamethasone—CYP19A1—lymph node—pharynx cancer	0.00171	0.00669	CbGeAlD
Dexamethasone—PTGS2—lymphoid tissue—pharynx cancer	0.00168	0.00658	CbGeAlD
Dexamethasone—CYP2E1—spinal cord—pharynx cancer	0.00165	0.00648	CbGeAlD
Dexamethasone—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.00164	0.00221	CbGpPWpGaD
Dexamethasone—NOS2—Spinal Cord Injury—EGFR—pharynx cancer	0.00164	0.00221	CbGpPWpGaD
Dexamethasone—ABCC2—lymph node—pharynx cancer	0.00163	0.00639	CbGeAlD
Dexamethasone—CYP1A1—head—pharynx cancer	0.00161	0.00632	CbGeAlD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.0016	0.00215	CbGpPWpGaD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.0016	0.00215	CbGpPWpGaD
Dexamethasone—CYP1B1—lymph node—pharynx cancer	0.0016	0.00626	CbGeAlD
Dexamethasone—ABCG2—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00159	0.00214	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—ADH1B—pharynx cancer	0.00159	0.00213	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—CNDP2—pharynx cancer	0.00158	0.00211	CbGpPWpGaD
Dexamethasone—CYP2B6—head—pharynx cancer	0.00157	0.00614	CbGeAlD
Dexamethasone—NR3C1—head—pharynx cancer	0.00156	0.00613	CbGeAlD
Dexamethasone—PTGS2—spinal cord—pharynx cancer	0.00152	0.00597	CbGeAlD
Dexamethasone—PLA2G1B—Metabolism—B4GALT5—pharynx cancer	0.00152	0.00204	CbGpPWpGaD
Dexamethasone—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00151	0.00203	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.0015	0.00202	CbGpPWpGaD
Dexamethasone—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.0015	0.00201	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00148	0.00199	CbGpPWpGaD
Dexamethasone—CYP2E1—head—pharynx cancer	0.00147	0.00576	CbGeAlD
Dexamethasone—CYP2A6—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00145	0.00194	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—ADH7—pharynx cancer	0.00142	0.00191	CbGpPWpGaD
Dexamethasone—NOS2—Disease—B4GALT5—pharynx cancer	0.00139	0.00187	CbGpPWpGaD
Dexamethasone—NOS2—Spinal Cord Injury—TP53—pharynx cancer	0.00138	0.00185	CbGpPWpGaD
Dexamethasone—PTGS2—head—pharynx cancer	0.00135	0.00531	CbGeAlD
Dexamethasone—ABCB1—epithelium—pharynx cancer	0.00135	0.00529	CbGeAlD
Dexamethasone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.00135	0.00181	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—CCND1—pharynx cancer	0.00133	0.00179	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—ADH1B—pharynx cancer	0.00125	0.00168	CbGpPWpGaD
Dexamethasone—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00125	0.00167	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00124	0.00167	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—CNDP2—pharynx cancer	0.00121	0.00162	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—B4GALT5—pharynx cancer	0.00119	0.0016	CbGpPWpGaD
Dexamethasone—ABCB1—trachea—pharynx cancer	0.00119	0.00468	CbGeAlD
Dexamethasone—ABCG2—lymph node—pharynx cancer	0.00119	0.00466	CbGeAlD
Dexamethasone—CYP2D6—head—pharynx cancer	0.00116	0.00456	CbGeAlD
Dexamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—pharynx cancer	0.00116	0.00156	CbGpPWpGaD
Dexamethasone—CYP1A1—lymph node—pharynx cancer	0.00113	0.00442	CbGeAlD
Dexamethasone—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00113	0.00151	CbGpPWpGaD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00111	0.00149	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—CNDP2—pharynx cancer	0.0011	0.00148	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.0011	0.00147	CbGpPWpGaD
Dexamethasone—NR3C1—lymph node—pharynx cancer	0.0011	0.00429	CbGeAlD
Dexamethasone—CYP4A11—Metabolism—CNDP2—pharynx cancer	0.00109	0.00147	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—ADH7—pharynx cancer	0.00109	0.00146	CbGpPWpGaD
Dexamethasone—ABCB1—lymphoid tissue—pharynx cancer	0.00104	0.00407	CbGeAlD
Dexamethasone—CYP11A1—Metabolism—ADH7—pharynx cancer	0.000997	0.00134	CbGpPWpGaD
Dexamethasone—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.000989	0.00133	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—ADH7—pharynx cancer	0.000987	0.00133	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.000984	0.00132	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.000984	0.00132	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—EGFR—pharynx cancer	0.000973	0.00131	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—CNDP2—pharynx cancer	0.000968	0.0013	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—ADH1B—pharynx cancer	0.000956	0.00128	CbGpPWpGaD
Dexamethasone—PTGS2—lymph node—pharynx cancer	0.000948	0.00371	CbGeAlD
Dexamethasone—ABCB1—spinal cord—pharynx cancer	0.000942	0.00369	CbGeAlD
Dexamethasone—CYP17A1—Metabolism—B4GALT5—pharynx cancer	0.000914	0.00123	CbGpPWpGaD
Dexamethasone—NOS2—Circadian rythm related genes—TP53—pharynx cancer	0.000901	0.00121	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—TP53—pharynx cancer	0.000878	0.00118	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—ADH7—pharynx cancer	0.000876	0.00118	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—ADH1B—pharynx cancer	0.000875	0.00117	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—CCND1—pharynx cancer	0.000873	0.00117	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—ADH1B—pharynx cancer	0.000866	0.00116	CbGpPWpGaD
Dexamethasone—ABCB1—head—pharynx cancer	0.000837	0.00328	CbGeAlD
Dexamethasone—CYP11A1—Metabolism—B4GALT5—pharynx cancer	0.000836	0.00112	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—B4GALT5—pharynx cancer	0.000827	0.00111	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.000817	0.0011	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—CNDP2—pharynx cancer	0.000808	0.00109	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.000774	0.00104	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—ADH1B—pharynx cancer	0.000768	0.00103	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—B4GALT5—pharynx cancer	0.000734	0.000985	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ADH7—pharynx cancer	0.000731	0.000981	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—CNDP2—pharynx cancer	0.000731	0.000981	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—CNDP2—pharynx cancer	0.000703	0.000944	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—CCND1—pharynx cancer	0.000665	0.000893	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ADH7—pharynx cancer	0.000661	0.000887	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.000641	0.000861	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ADH1B—pharynx cancer	0.000641	0.000861	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CNDP2—pharynx cancer	0.00064	0.000859	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ADH7—pharynx cancer	0.000636	0.000854	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CNDP2—pharynx cancer	0.000634	0.000852	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—B4GALT5—pharynx cancer	0.000613	0.000822	CbGpPWpGaD
Dexamethasone—ABCB1—lymph node—pharynx cancer	0.000586	0.0023	CbGeAlD
Dexamethasone—CYP2A6—Metabolism—CNDP2—pharynx cancer	0.000581	0.000781	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ADH1B—pharynx cancer	0.000579	0.000778	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ADH7—pharynx cancer	0.000579	0.000777	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ADH7—pharynx cancer	0.000574	0.00077	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ADH1B—pharynx cancer	0.000558	0.000749	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—B4GALT5—pharynx cancer	0.000554	0.000743	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.000538	0.000723	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—B4GALT5—pharynx cancer	0.000533	0.000716	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ADH7—pharynx cancer	0.000526	0.000706	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—EGFR—pharynx cancer	0.000522	0.000701	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ADH1B—pharynx cancer	0.000508	0.000681	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ADH1B—pharynx cancer	0.000503	0.000675	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CNDP2—pharynx cancer	0.000488	0.000655	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—B4GALT5—pharynx cancer	0.000485	0.000651	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—B4GALT5—pharynx cancer	0.000481	0.000645	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CNDP2—pharynx cancer	0.000469	0.00063	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ADH1B—pharynx cancer	0.000461	0.000619	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CNDP2—pharynx cancer	0.00046	0.000617	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.000459	0.000616	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000453	0.000608	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—B4GALT5—pharynx cancer	0.000442	0.000593	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ADH7—pharynx cancer	0.000441	0.000593	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—B4GALT5—pharynx cancer	0.000441	0.000592	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TP53—pharynx cancer	0.000438	0.000588	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CNDP2—pharynx cancer	0.000433	0.000582	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—TP53—pharynx cancer	0.000431	0.000578	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ADH7—pharynx cancer	0.000424	0.00057	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ADH7—pharynx cancer	0.000416	0.000558	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ADH7—pharynx cancer	0.000415	0.000557	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.000397	0.000533	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ADH7—pharynx cancer	0.000392	0.000526	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—EGFR—pharynx cancer	0.00039	0.000524	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ADH1B—pharynx cancer	0.000387	0.00052	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ADH1B—pharynx cancer	0.000372	0.000499	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—B4GALT5—pharynx cancer	0.00037	0.000497	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ADH1B—pharynx cancer	0.000364	0.000489	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.000364	0.000488	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000359	0.000482	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—B4GALT5—pharynx cancer	0.000356	0.000477	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000355	0.000477	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.000355	0.000476	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—B4GALT5—pharynx cancer	0.000348	0.000468	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.000348	0.000467	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000346	0.000465	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ADH1B—pharynx cancer	0.000344	0.000461	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—B4GALT5—pharynx cancer	0.000328	0.000441	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000326	0.000438	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.000323	0.000434	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000321	0.000431	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ADH7—pharynx cancer	0.000321	0.00043	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000315	0.000423	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ADH7—pharynx cancer	0.000313	0.00042	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000301	0.000404	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000298	0.0004	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000295	0.000396	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCND1—pharynx cancer	0.000294	0.000395	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ADH7—pharynx cancer	0.000292	0.000392	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.000281	0.000377	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ADH1B—pharynx cancer	0.000274	0.000368	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.000269	0.000361	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000262	0.000352	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000259	0.000347	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.000256	0.000344	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000252	0.000338	CbGpPWpGaD
Dexamethasone—NOS2—Disease—EGFR—pharynx cancer	0.000248	0.000333	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000247	0.000332	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.000245	0.000329	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—EGFR—pharynx cancer	0.000231	0.00031	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000213	0.000286	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000211	0.000284	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—pharynx cancer	0.000194	0.00026	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000193	0.000259	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000169	0.000227	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000162	0.000217	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCND1—pharynx cancer	0.000161	0.000216	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—pharynx cancer	0.000126	0.000169	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—pharynx cancer	0.000106	0.000142	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—pharynx cancer	7.88e-05	0.000106	CbGpPWpGaD
